期刊文献+

白芍总苷对系统性红斑狼疮患者外周血B细胞内TLR9表达的影响 被引量:14

Effect of Total Glucosides of Paeony on the Expression of Toll-like Receptor 9 in Peripheral Blood B Cells of Patients with Systemic Lupus Erythematosus
暂未订购
导出
摘要 目的探讨白芍总苷(TGP)对系统性红斑狼疮(SLE)患者外周血B细胞内Toll样受体9(TLR9)表达的影响。方法选取SLE患者60例和正常健康人30例,分离外周血单个核细胞(PBMC),每份标本均分为4组体外培养,即空白对照组、胞嘧啶-磷酸-鸟嘌呤-寡聚脱氧核苷酸(Cp G-ODN)组、Cp G-ODN+TGP组和TGP组。空白对照组仅加入RPMI-1640完全培养液,其他3组分别加入Cp G-ODN(ODN终浓度1μmol·L-1)、Cp G-ODN+TPG(TPG最适终浓度为1×10-4mol·L-1)、TPG。各组均培养48 h后提取细胞,应用流式细胞仪检测各组B细胞内TLR9表达。结果 1正常健康人:Cp G-ODN组和空白对照组TLR9的表达率分别为(9.10±2.12)%,(4.96±2.11)%(P<0.01);2SLE患者:Cp G-ODN组的TLR9表达率(14.86±3.42)%,显著高于空白对照组的(9.20±3.43)%(P<0.01),Cp G-ODN+TGP组的TLR9表达率(11.95±3.63)%,低于Cp G-ODN组(P<0.05);在SLE轻度活动患者中,Cp G-ODN组和空白对照组TLR9的表达率分别为(10.74±3.17)%,(5.19±2.05)%(P<0.05);在SLE中重度活动患者中,Cp G-ODN组和空白对照组TLR9的表达率分别为(16.51±1.72)%,(10.80±2.37)%(P<0.01),Cp G-ODN+TGP组TLR9的表达率(13.59±2.58)%,低于Cp G-ODN组(P<0.01)。结论 TGP可以拮抗Cp G-ODN对B细胞内TLR9表达的上调作用。 Objective To investigate the effect of total glucosides of paeony ( TGP ) on the expression of Toll-like receptor 9 (TLR9) in peripheral blood B lymphocytes of the patients with systemic lupus erythematosus (SLE). Methods Sixty SLE patients and thirty healthy volunteers were enrolled, peripheral blood mononuclear cells ( PBMC) were isolated from blood samples and divided into 4 groups, which were incubated with CpG-ODN(final concentration was 1 μmol·L^-1), CpG-ODN+TGP ( TPG final concentration was 1×10^-4 mol·L^-1 ) ,TGP and RPMI medium ( as the blank control group) for 48 hours, respectively. FLA ( Flow cytometry analysis) was used to detect the expression of TLR9 on peripheral blood B lymphocytes after incubated. Results ①In the health people, TLR9 expression in the group of CpG-ODN was(9. 10±2. 12) %, which was higher than the blank control group(4. 96±2. 11) % (P〈0. 01).②In the SLE patients, the TLR9 expression in the group of CpG-ODN was(14. 86±3. 42)% , which was significantly higher than the blank control group(9. 20±3. 43) %(P〈0. 01). The TLR9 expression in the group of CpG-ODN+TGP was (11. 95±3. 63)%, which was lower than that in the group of CpG-ODN (P〈0. 05). The TLR9 expression in the group of CpG-ODN with lightly active degree SLE patients was (10. 74±3. 17)%, which was higher than the blank control group(5. 19±2. 05) % (P〈0. 01). For SLE from the moderately to vigorously active degree, the expression of TLR9 in the group of CpG-ODN(16. 51±1. 72) % was higher than the blank control group(10. 80±2. 37) %(P〈0. 01), but that in the group of CpG-ODN+TGP (13. 59±2. 58) % was lower than the group of CpG-ODN (P〈0. 01). Conclusion Our data indicate that TGP antagonize upregulation effect of CpG-ODN on the expression of TLR9 in peripheral blood B lymphocytes.
出处 《医药导报》 CAS 2015年第5期589-593,共5页 Herald of Medicine
基金 蚌埠医学院校自然科学项目(Byky1352)
关键词 白芍总苷 红斑狼疮 系统性 寡聚脱氧核苷酸 TOLL样受体 Total glucosides of paeony Lupus erythematosus,systemic Oligodeoxynucleotides Toll-like receptor
  • 相关文献

参考文献20

  • 1RICHEZ C, BLANCO, RIFRIN I, et al. Role for Toll-like receptors in autoimmune disease:the example of systemic lupus erythematosus [ J ]. Joint Bone Spine, 2011,78 ( 2 ) : 124-130.
  • 2GUIDUCCI C, GONG M, XU Z, et al. TLR recognition of self nucleic acids hampers glucocorticoid activity i.n lupus [ J]. Nature ,2010,465 (7300) :937-941.
  • 3李传应,王春,魏伟.白芍总苷对小鼠慢性皮炎-湿疹的治疗作用及其部分机制[J].中国药理学通报,2008,24(10):1366-1369. 被引量:62
  • 4祝玉慧,魏春华.白芍总甙联合小剂量激素治疗系统性红斑狼疮35例临床观察[J].山东医药,2009,49(5):100-101. 被引量:10
  • 5HOCHBERG M C. Updating the American college of rheu- matology revised criteria for the classification of systemic lupus erythematosus [ J]. Arthritis Rheum, 1997,40 ( 9 ) : 1725-1730.
  • 6BOMBARDIER C, GLADMAN D D, UROWITZ M B, et al. Derivation of the SLEDAI, a disease activity index for lupus patients the committee on prognosis studies in SLE [ J 3- Arthritis Rheum, 1992,35 ( 6 ) : 630-640.
  • 7CELHAR T, MAGALHAES R, FAIRHURST A M. TLR7 and TLR9 in SLE: when sensing self goes wrong [ J l- Immunol Res ,2012,53 ( 1-3 ) :58-77.
  • 8KLINMAN D M. Immunotherapeutie uses of CpG oligodeo- xynucleotides [ J ]. Nat Rev Immunol, 2004,4 (4) : 249 - 258.
  • 9HARTMANN G, BATI'IANY J, POECK H, et al. Rational design of new CpG oligonueleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritie cells [ J ]. Eur J Immunol, 2003,33 ( 6 ) : 1633 - 1641.
  • 10NIEWORD T B. Interferon alpha as a primary pathogenic factor in human lupus[ J]. J Interferon Cytokine Res ,2011, 31 (12) :887-892.

二级参考文献59

共引文献125

同被引文献177

引证文献14

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部